722 related articles for article (PubMed ID: 16176115)
1. Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach.
Anderson GD
Clin Pharmacokinet; 2005; 44(10):989-1008. PubMed ID: 16176115
[TBL] [Abstract][Full Text] [Related]
2. Optimizing pediatric dosing: a developmental pharmacologic approach.
Anderson GD; Lynn AM
Pharmacotherapy; 2009 Jun; 29(6):680-90. PubMed ID: 19476420
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic drug interactions between clobazam and drugs metabolized by cytochrome P450 isoenzymes.
Walzer M; Bekersky I; Blum RA; Tolbert D
Pharmacotherapy; 2012 Apr; 32(4):340-53. PubMed ID: 22422635
[TBL] [Abstract][Full Text] [Related]
4. Using pharmacokinetics to predict the effects of pregnancy and maternal-infant transfer of drugs during lactation.
Anderson GD
Expert Opin Drug Metab Toxicol; 2006 Dec; 2(6):947-60. PubMed ID: 17125410
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous Screening of Activities of Five Cytochrome P450 and Four Uridine 5'-Diphospho-glucuronosyltransferase Enzymes in Human Liver Microsomes Using Cocktail Incubation and Liquid Chromatography-Tandem Mass Spectrometry.
Lee B; Ji HK; Lee T; Liu KH
Drug Metab Dispos; 2015 Jul; 43(7):1137-46. PubMed ID: 25904760
[TBL] [Abstract][Full Text] [Related]
6. Developmental pharmacokinetics.
Anderson GD
Semin Pediatr Neurol; 2010 Dec; 17(4):208-13. PubMed ID: 21183126
[TBL] [Abstract][Full Text] [Related]
7. Impact of obesity on drug metabolism and elimination in adults and children.
Brill MJ; Diepstraten J; van Rongen A; van Kralingen S; van den Anker JN; Knibbe CA
Clin Pharmacokinet; 2012 May; 51(5):277-304. PubMed ID: 22448619
[TBL] [Abstract][Full Text] [Related]
8. Guidelines on paediatric dosing on the basis of developmental physiology and pharmacokinetic considerations.
Bartelink IH; Rademaker CM; Schobben AF; van den Anker JN
Clin Pharmacokinet; 2006; 45(11):1077-97. PubMed ID: 17048973
[TBL] [Abstract][Full Text] [Related]
9. A mechanistic approach for the scaling of clearance in children.
Edginton AN; Schmitt W; Voith B; Willmann S
Clin Pharmacokinet; 2006; 45(7):683-704. PubMed ID: 16802850
[TBL] [Abstract][Full Text] [Related]
10. Ontogeny of hepatic and renal systemic clearance pathways in infants: part II.
Alcorn J; McNamara PJ
Clin Pharmacokinet; 2002; 41(13):1077-94. PubMed ID: 12403644
[TBL] [Abstract][Full Text] [Related]
11. The pharmacokinetics of antiarrhythmic agents in pregnancy and lactation.
Mitani GM; Steinberg I; Lien EJ; Harrison EC; Elkayam U
Clin Pharmacokinet; 1987 Apr; 12(4):253-91. PubMed ID: 3297463
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphisms of drug-metabolising enzymes and drug transporters in the chemotherapeutic treatment of cancer.
Bosch TM; Meijerman I; Beijnen JH; Schellens JH
Clin Pharmacokinet; 2006; 45(3):253-85. PubMed ID: 16509759
[TBL] [Abstract][Full Text] [Related]
13. Absolute protein quantification of clinically relevant cytochrome P450 enzymes and UDP-glucuronosyltransferases by mass spectrometry-based targeted proteomics.
Gröer C; Busch D; Patrzyk M; Beyer K; Busemann A; Heidecke CD; Drozdzik M; Siegmund W; Oswald S
J Pharm Biomed Anal; 2014 Nov; 100():393-401. PubMed ID: 25218440
[TBL] [Abstract][Full Text] [Related]
14. A Physiologically Based Pharmacokinetic Model for Pregnant Women to Predict the Pharmacokinetics of Drugs Metabolized Via Several Enzymatic Pathways.
Dallmann A; Ince I; Coboeken K; Eissing T; Hempel G
Clin Pharmacokinet; 2018 Jun; 57(6):749-768. PubMed ID: 28924743
[TBL] [Abstract][Full Text] [Related]
15. In vitro characterization of the metabolic pathways and cytochrome P450 inhibition and induction potential of BMS-690514, an ErbB/vascular endothelial growth factor receptor inhibitor.
Hong H; Su H; Ma L; Yao M; Iyer RA; Humphreys WG; Christopher LJ
Drug Metab Dispos; 2011 Sep; 39(9):1658-67. PubMed ID: 21673131
[TBL] [Abstract][Full Text] [Related]
16. Drug transfer and metabolism by the human placenta.
Syme MR; Paxton JW; Keelan JA
Clin Pharmacokinet; 2004; 43(8):487-514. PubMed ID: 15170365
[TBL] [Abstract][Full Text] [Related]
17. Cytochrome P450 3A: ontogeny and drug disposition.
de Wildt SN; Kearns GL; Leeder JS; van den Anker JN
Clin Pharmacokinet; 1999 Dec; 37(6):485-505. PubMed ID: 10628899
[TBL] [Abstract][Full Text] [Related]
18. Gender differences in pharmacological response.
Anderson GD
Int Rev Neurobiol; 2008; 83():1-10. PubMed ID: 18929073
[TBL] [Abstract][Full Text] [Related]
19. [Role of monoxygenases in the metabolism of drugs in the human fetus and newborn infant].
Cresteil T; Leroux JP
Arch Fr Pediatr; 1982; 39(7):463-70. PubMed ID: 6816186
[TBL] [Abstract][Full Text] [Related]
20. Use of probe drugs as predictors of drug metabolism in humans.
Kivistö KT; Kroemer HK
J Clin Pharmacol; 1997 Jan; 37(S1):40S-48S. PubMed ID: 9048284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
